Xtrackers II EUR High Yield Corporate Bond UCITS ETF 1D is a bonds ETF from Xtrackers tracking the High Yield Corporate Bond index through physical replication. Domiciled in Luxembourg and launched in 2015, the fund manages about 1.1 bn € and charges a TER of 0.23% — 23 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Xtrackers II EUR High Yield Corporate Bond UCITS ETF 1D competes with 3 other products on the same index (High Yield Corporate Bond): it ranks 1st by fund size and 3rd by ongoing cost, with a TER of 0.23% against a group median of 0.22%. It has been listed since 2015, 11 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 23 € a year. The cheapest of the group is Xtrackers USD High Yield Corporate Bond UCITS ETF 1D CHF at 0.20%, or 20 € on the same amount: a difference of 3 € every year, roughly 30 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 4.3% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| Intesa Sanpaolo S.p.A. 6.625% | 0.5% |
| Nidda Healthcare Holding GmbH 3.5% | 0.5% |
| UniCredit S.p.A. 6.95% | 0.5% |
| Netflix, Inc. 3.625% | 0.4% |
| Thyssenkrupp AG 2.875% | 0.4% |
| Altice Luxembourg S.A. 8% | 0.4% |
| Deutsche Bank AG 2.75% | 0.4% |
| Telecom Italia S.p.A. 4% | 0.4% |
| Teva Pharmaceutical Finance Netherlands II B.V 1.125% | 0.4% |
| Douglas GmbH 6% | 0.4% |
| Borsa Italiana | XHYG | EUR |
| XETRA | XHYG | EUR |
| Francoforte | XHYG | EUR |
| London Stock Exchange | XHYG | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.